Balucan, Rojay .
HRN: 24-13-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2023
CO-AMOXICLAV 625MG (TAB)
11/28/2023
12/05/2023
PO
625mg
Bid
Rmle And Repair
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes